Cellular mRNAs exist in messenger ribonucleoprotein (mRNP) complexes, which undergo transitions during the lifetime of the mRNAs and direct posttranscriptional gene regulation. A final posttranscriptional step in gene expression is the turnover of the mRNP, which involves degradation of the mRNA and recycling of associated proteins. How tightly associated protein components are released from degrading mRNPs is unknown. Here, we demonstrate that the ATPase activity of the RNA helicase Upf1 allows disassembly of mRNPs undergoing nonsense-mediated mRNA decay (NMD). In the absence of Upf1 ATPase activity, partially degraded NMD mRNA intermediates accumulate in complex with NMD factors and concentrate in processing bodies. Thus, disassembly and completion of turnover of mRNPs undergoing NMD requires ATP hydrolysis by Upf1. This uncovers a previously unappreciated and potentially regulated step in mRNA decay and raises the question of how other mRNA decay pathways release protein components of substrate mRNPs.
INTRODUCTION
mRNA decay is a critical step in the regulation of gene expression. The stability of mRNAs can vary by orders of magnitude and is dictated by the composition of the messenger ribonucleoprotein (mRNP) (Balagopal and Parker, 2009; Moore, 2005) . How decay-promoting mRNP components activate mRNA turnover is poorly understood. Several studies have shown evidence that the recruitment of mRNA decay enzymes is a critical step in mRNA turnover (Cho et al., 2009; Gherzi et al., 2004; Lykke-Andersen and Wagner, 2005; Moraes et al., 2006 ). Yet, it is unknown how recruited mRNA decay enzymes access the mRNA through stably associated protein components of the mRNP. In an analogous manner, early models for transcription activation focused on the recruitment of RNA polymerase, whereas later studies demonstrated the importance of chromatin modification and remodeling (Campos and Reinberg, 2009) . Does the mRNP constitute an obstacle to mRNA turnover as chromatin does to transcription?
Evidence primarily from the yeast Saccharomyces cerevisiae suggests that mRNA degradation generally initiates with removal of the mRNA poly(A)-tail by deadenylases, which stimulates either mRNA decapping and subsequent 5 0 -to-3 0 exonucleolytic decay by Xrn1 (Doma and Parker, 2007; Garneau et al., 2007) or degradation in the 3 0 -to-5 0 direction by the exosome (Schmid and Jensen, 2008) . In addition, some mRNA decay pathways trigger endonucleolytic cleavage followed by 3 0 -to-5 0 and 5 0 -to-3 0 exonucleolytic decay of the mRNA fragments by the exosome and Xrn1, respectively (Wilusz, 2009 ). However, although much has been learned about the enzymes that degrade mRNAs, it remains unknown how the mRNA decay enzymes negotiate the mRNP.
Nonsense-mediated mRNA decay (NMD) is an mRNA turnover pathway that targets mRNAs with premature translation termination codons (PTCs) for rapid degradation, thereby suppressing protein expression from aberrant mRNAs, as well as a subset of normal NMD-regulated mRNAs (Amrani et al., 2006; BehmAnsmant et al., 2007; Chang et al., 2007; Isken and Maquat, 2007; Mü hlemann et al., 2008; Rebbapragada and LykkeAndersen, 2009 ). How a termination codon is recognized as premature remains under investigation, but it appears to occur when a ribosome terminates translation sufficiently upstream of a normal 3 0 UTR to prevent 3 0 UTR-associated proteins, including cytoplasmic poly(A)-binding protein (PABPC), from stimulating a proper termination event (Amrani et al., 2006; Mü hlemann et al., 2008; Rebbapragada and Lykke-Andersen, 2009 ). This initiates the assembly of an NMD mRNP with the recruitment of the NMD factor Upf1 and its cofactors Upf2 and Upf3 to the terminating ribosome. In vertebrates, NMD is strongly stimulated when an exon junction complex (EJC), which interacts with the Upf complex, is positioned downstream of the termination event Isken and Maquat, 2007; Moore and Proudfoot, 2009; Mü hlemann, 2008; Rebbapragada and Lykke-Andersen, 2009 ). In metazoans, the NMD mRNP is further modulated by a phosphorylation-dephosphorylation cycle of Upf1 mediated by the kinase Smg1 and by protein phosphatase 2A in association with the NMD factors Smg5 and Smg7 (Fukuhara et al., 2005; Glavan et al., 2006; Ohnishi et al., 2003; Page et al., 1999; Yamashita et al., 2001) . The assembled NMD mRNP subsequently recruits mRNA decay enzymes to initiate mRNA degradation. Depending on the specific organism, decay can initiate by decapping, deadenylation, and/or endonucleolytic cleavage (Mü hlemann and Lykke-Andersen, 2010) . Recent evidence suggests that in human and Drosophila cells, decay of the NMD substrate is primarily initiated by endonucleolytic cleavage by the NMD factor Smg6 followed by 3 0 -to-5 0 and 5 0 -to-3 0 exonucleolytic decay of the mRNA fragments by the exosome and Xrn1, respectively (Gatfield and Izaurralde, 2004; Glavan et al., 2006; Huntzinger et al., 2008; Eberle et al., 2009 ). However, it remains an unresolved question how the NMD factors are recycled from the degrading NMD mRNP. Are they released by the activity of the mRNA decay enzymes or do they require active removal prior to or during mRNA decay?
A central component of the NMD pathway, Upf1, belongs to helicase superfamily 1 and shows RNA-dependent ATPase and 5 0 -to-3 0 RNA helicase activities in vitro (Bhattacharya et al., 2000; Chamieh et al., 2008; Cheng et al., 2007; Czaplinski et al., 1995) . The ATPase activity of Upf1 is critical to the NMD pathway (Kashima et al., 2006; Weng et al., 1996a) ; however, its specific role remains unresolved. Although helicases were first described as ATPases that unwind polynucleotide duplexes, several helicases of superfamily 2 have more recently been shown to function as RNPases that promote ATP-dependent mRNP remodeling in the absence of double-stranded RNA (Fairman et al., 2004; Jankowsky et al., 2001) . Early studies implicated the Upf1 ATPase at the translation termination step of yeast NMD , but more recent observations in yeast show that ATPase-deficient mutant Upf1 accumulates with NMD substrates in cytoplasmic mRNP granules called processing bodies (PBs) (Cheng et al., 2007; Sheth and Parker, 2006) . This suggests that the failure of Upf1 to hydrolyze ATP causes the accumulation of an NMD mRNP in association with mRNA decay factors. Here, we demonstrate that the Upf1 ATPase stimulates the removal and recycling of NMD factors from mRNPs targeted for NMD. This is required for the completion of exonucleolytic decay of the NMD substrate. In the absence of Upf1 ATPase activity, NMD factors become trapped with partially degraded 3 0 NMD mRNP intermediates. This demonstrates the importance of mRNP disassembly in mRNA turnover, and raises the questions of whether this is a regulated step in NMD and to what extent mRNP disassembly is a critical step in other mRNA decay pathways.
RESULTS

The 3
0 Fragment Generated upon Endonucleolytic Cleavage of NMD mRNA Substrates Accumulates in the Presence of ATPase-Deficient Upf1 To investigate the function of Upf1 ATPase activity in NMD, we tested the effect of impairing human (h)Upf1 ATP binding and hydrolysis on the degradation of NMD substrate mRNAs. A b-globin mRNA with a PTC at position 39 (b-39) was subjected to pulse-chase mRNA decay assays in human HeLa Tet-off cells, in which endogenous hUpf1 was depleted with an siRNA and replaced with exogenous siRNA-resistant wild-type hUpf1 (hUpf1 R ), or mutants thereof that fail to hydrolyze (hUpf1 DEAA R ) or fail to bind (hUpf1 K498A R ) ATP (Bhattacharya et al., 2000; Cheng et al., 2007) . As expected, the b-39 NMD substrate is significantly more stable in the presence of hUpf1 ATPase mutants than with wild-type hUpf1 ( Figure 1A , top panel; see band labeled b-39). Surprisingly, however, a fast migrating mRNA species (indicated by an arrow in Figure 1A ) accumulates when hUpf1 ATPase mutant proteins are expressed, but is not observed in the presence of wild-type hUpf1 ( Figure 1A , top panel; quantified in Figure 1B ). This product corresponds to the 3 0 fragment of the NMD substrate following endonucleolytic cleavage by Smg6, because it is not observed with a probe specific to the 5 0 end of b-globin mRNA and is strongly reduced under Smg6 knockdown conditions (see Figures S1A-S1C available online). In contrast to the 3 0 fragment, no 5 0 fragment was detectable upon hUpf1 ATPase mutant expression (Figure 1A and Figure S1D ). Thus, ATPase-deficient hUpf1 allows endonucleolytic cleavage of the NMD substrate, followed by exonucleolytic decay of the resulting 5 0 product, but impairs the degradation of the 3 0 product. How can the failure of hUpf1 to bind or to hydrolyze ATP specifically affect the NMD substrate 3 0 decay intermediate? One possibility is that the 3 0 intermediate requires Upf1 ATPase activity to be accessible to Xrn1, the 5 0 -to-3 0 exonuclease that normally degrades this fragment (Gatfield and Izaurralde, 2004; Huntzinger et al., 2008; Eberle et al., 2009) . If so, the same fragment should accumulate upon depletion of Xrn1 in the presence of both wild-type and ATPase-deficient hUpf1. To test this idea, Xrn1 was depleted with siRNAs that modestly (Xrn1 #1) or strongly (Xrn1 #2) reduce Xrn1 levels ( Figure 1C ), and the effect on the decay of the b-39 mRNA was monitored. As seen in Figure 1A (middle panel), when Xrn1 is modestly depleted, the b-39 mRNA 3 0 fragment accumulates strongly in the presence of ATPase-deficient hUpf1, but not with wild-type hUpf1. Only when Xrn1 is strongly depleted does the 3 0 b-39 mRNA fragment accumulate in cells expressing wild-type hUpf1 ( Figure 1A , bottom panel; quantified in Figure 1B ). However, even under these conditions, the resulting 3 0 mRNA fragment is rapidly degraded with an apparent half-life 2-4-fold shorter than that observed when hUpf1 ATPase mutants are expressed. A similar pattern of NMD substrate 3 0 fragment accumulation was observed when a different NMD substrate, GPx1-46, was tested ( Figure 1D ). These observations are not a result of globally impaired Xrn1 activity, because Xrn1-mediated degradation of the 3 0 fragment of a b-globin reporter mRNA subjected to endonucleolytic cleavage by endogenous let-7 microRNA is not impaired in the presence of ATPase-deficient hUpf1 ( Figure S1E ). Thus, although it is well established that the Upf1 protein plays a key role in the recognition step of NMD (Amrani et al., 2006; Kashima et al., 2006; Mü hlemann et al., 2008; Ohnishi et al., 2003; Rebbapragada and Lykke-Andersen, 2009 ), the observations shown here suggest that the ATPase activity of Upf1 is required at a later step in NMD (Figure 1 ). Consistent with this, when mRNA decay is initiated by tethered hUpf1, thereby bypassing the Upf1 recruitment step of NMD (Lykke-Andersen et al., 2000), ATP binding-deficient hUpf1 causes accumulation of a 3 0 fragment that is not observed with tethered wild-type Upf1 unless Xrn1 is efficiently knocked down ( Figure S1F ).
ATPase-Deficient hUpf1 Accumulates on the 3 0 NMD Intermediate How does the Upf1 ATPase stimulate degradation of the 3 0 NMD fragment by Xrn1? One possibility is that the Upf1 ATPase triggers removal of protein from the 3 0 NMD mRNP intermediate, thereby allowing access for Xrn1. If so, it is predicted that wildtype hUpf1 should cycle off the 3 0 NMD intermediate, whereas ATPase-deficient hUpf1 should fail to do so. This idea was tested using hUpf1 immunoprecipitation (IP) followed by Northern blotting for associated NMD substrate mRNA under strong Xrn1 knock-down conditions. As seen in Figure 2A , both wildtype and mutant hUpf1 proteins associate with full-length b-39 NMD substrate produced by a short transcriptional pulse (lanes 6-8). However, the association of the accumulating 3 0 b-39 fragment with ATPase-deficient hUpf1 is strongly enhanced (4.1-fold relative to full-length b-39) as compared with wildtype hUpf1 (Figure 2A ; compare lanes 7 and 8 to lane 6; band marked by arrow). These interactions occur in the cell and do not form after cell lysis, because b-39 mRNA does not copurify with wild-type or mutant hUpf1 when expressed in separate cells and combined during cell lysis ( Figure 2B ; compare lanes 6 to 5 and lanes 12 to 11), and the mRNA substrate does not copurify with the antibody in the absence of exogenous hUpf1 ( Figure 2A , lane 5, and Figure 2B , lanes 4 and 10). These observations are consistent with the idea that ATPase activity is not critical for recruitment of hUpf1 to the NMD substrate, but is required for the release of hUpf1 from the 3 0 fragment that forms after initiation of mRNA decay. exonucleolytic decay if protein is removed from the mRNP. To test this idea in vitro, b-39 mRNA was expressed along with exogenous wild-type or ATPase-deficient hUpf1 proteins in HeLa Tet-off cells depleted for endogenous Xrn1 and hUpf1. Cells were subsequently permeabilized, and the resulting cell extracts were incubated with the Terminator enzyme, a commercially available 5 0 -to-3 0 exonuclease. As seen in Figure 2C (left panels), although the 3 0 NMD mRNA fragment that accumulates as a result of Xrn1 knock-down in the presence of wild-type hUpf1 is degraded efficiently (t 1/2 z 18 min), a large fraction (60%-70%) of the same RNA produced in cells expressing ATPase-deficient Upf1 proteins is highly resistant to 5 0 -to-3 0 exonucleolytic decay (quantified in Figure 2D , top panel). In contrast, when mRNPs were disrupted and protein removed from the cell extracts by phenol extraction prior to incubation with the nuclease, the 3 0 NMD fragment is degraded efficiently regardless of the ability of Upf1 to hydrolyze ATP ( Figure 2C , right panels; quantified in Figure 2D , bottom panel). As expected, full-length b-39 mRNA is resistant to the Terminator enzyme, which is specific for 5 0 monophosphate-containing RNA and thus does not target capped RNA ( Figure 2C ; upper bands), and the 3 0 fragment does not degrade in the absence of Terminator (bottom panels). When the endonuclease RNase A was used in place of Terminator, all RNAs rapidly degrade ( Figure S2 ). Thus, when Upf1 fails to hydrolyze ATP, the 3 0 NMD fragment generated by Smg6-mediated endonucleolytic cleavage becomes trapped in an mRNP that includes hUpf1 and is resistant to exonucleolytic decay from the 5 0 end.
The 3 0 NMD Intermediate Accumulates in PBs in the Presence of ATPase-Deficient Upf1
A number of studies have demonstrated that cytoplasmic mRNPs that accumulate in association with 5 0 -to-3 0 mRNA decay complexes concentrate in PBs (Eulalio et al., 2007; Franks and Lykke-Andersen, 2008; Parker and Sheth, 2007) . Thus, if hUpf1 ATPase activity is critical for NMD mRNP disassembly during mRNA decay, it is predicted that the NMD intermediate should accumulate in PBs when hUpf1 fails to hydrolyze ATP. Indeed, as seen in the fluorescence in situ hybridization (FISH) assays in Figure 3A , both b-39 (panels 2 and 3) and GPx1-46 (panels 5 and 6) mRNAs accumulate strongly in PBs in the presence of ATPase-deficient hUpf1, but are rarely detected when wild-type hUpf1 is expressed (panels 1 and 4). This finding is consistent with previous observations in yeast (Sheth and Parker, 2006) . In contrast, wild-type b-globin mRNA accumulated only at very low levels in PBs upon mutant hUpf1 expression ( Figure S3 ).
We next used individual probes hybridizing to different regions along the b-globin mRNA to ask which part of the NMD substrate accumulates in PBs. Remarkably, although the region 3 0 of the PTC of b-39 mRNA was readily detectable in PBs in the presence of ATPase-deficient hUpf1, the 5 0 end remained completely undetectable in PBs ( Figure 3B , compare panels 4 and 5 with panels 1 and 2; quantifications below), despite the fact that the full-length mRNA under these conditions is 6-10-fold more abundant than the 3 0 fragment (Figures 1A and 1B) . A probe that hybridizes across the mapped Smg6 endonucleolytic cleavage sites (Eberle et al., 2009 ) modestly detects the mRNA in PBs (panel 3). The observed differences in PB detection are not due to different efficiencies of the FISH probes, because, in contrast to the b-39 mRNA, each FISH probe equally detected in PBs a b-globin mRNA targeted for the ARE-mRNA decay pathway (b-ARE) (compare panels 6-10 with panels 1-5; quantifications below). The observed localization pattern is not unique to the b-39 mRNA, as in the presence of ATPase-deficient hUpf1 the 3 0 end of an unrelated NMD substrate, GPx1-46, could also be observed in PBs in contrast to its 5 0 end ( Figure 3C ). Thus, the 3 0 NMD mRNA decay intermediate that accumulates when Upf1 fails to hydrolyze ATP forms an mRNP that concentrates in PBs.
Multiple NMD Factors Accumulate in PBs in the Absence of Upf1 ATPase Activity What are the protein components of the accumulating 3 0 NMD mRNP intermediate? On the basis of the observations above, such proteins are predicted (1) to accumulate in PBs in the presence of ATPase-deficient Upf1, (2) to copurify more strongly with ATPase-deficient Upf1 than with wild-type Upf1 in coimmunoprecipitation (co-IP) assays, and (3) to copurify the NMD mRNA 3 0 fragment when immunoprecipitated. We tested these predictions for multiple NMD factors. Consistent with hUpf1 being part of the 3 0 NMD mRNP and with previous observations in yeast and human cells (Sheth and Parker, 2006; Cheng et al., 2007; Cho et al., 2009; Stalder and Muhlemann, 2009) , indirect immunofluorescence assays revealed that ATP binding-and ATPasedeficient mutant hUpf1 proteins, but not wild-type hUpf1, accumulate strongly in PBs (Figure 4 , compare panels 4, 7, 10, 13 to panel 1). This is consistent with the observation that ATPase activity is required for the release of hUpf1 from the degrading NMD mRNP (Figure 2A ).
What about other NMD factors? Remarkably, exogenously expressed ATPase-deficient hUpf1 ( Figure 5A ), but not wild-type hUpf1 ( Figure 5B ), induces strong accumulation of endogenous Smg5, Smg6, and Smg7 in PBs (panels 4, 7, and 10; transfected cells identified by the coexpression of NLS-DsRed are marked by arrowheads) but has no observable effect on the localization of an unrelated RNA-binding protein, HuR (panel 28). Smg1, hUpf2, and the EJC components Y14 and eIF4A3 more modestly accumulate in PBs (panels 13, 16, 19, and 22), whereas hUpf3a and hUpf3b were only rarely observed in PBs (unpublished data). None of the NMD factors localized strongly in PBs in untransfected cells (Figures 5A and 5B ; cells not indicated by arrowheads), which in all cases looked similar to those expressing exogenous wild-type hUpf1 ( Figure 5B ). Similarly to NMD factors, Xrn1 consistently showed enhanced accumulation in PBs in cells expressing ATPase-deficient hUpf1 ( Figure 5A more strongly with ATPase-deficient hUpf1 mutant proteins than with wild-type hUpf1 in co-IP assays. In striking correlation with the immunofluorescence assays above, the co-IP assays in Figure 6A (lanes 1-8), in which cell extracts were not treated with RNase, show strong enrichment of endogenous Smg5 and Smg7 and exogenous Smg6 in hUpf1 ATPase mutant protein complexes, compared with wild-type hUpf1 complexes (compare lanes 3 and 4 with lane 2) (see also Figure S4 ). Other NMD factors, hUpf2, hUpf3b, and eIF4A3 show modestly enhanced accumulation with hUpf1 ATPase mutant complexes ( Figure 6A ), which correlates well with their moderate accumulation in PBs under the same conditions ( Figure 5A ) (our anti-hSmg6 and anti-hSmg1 antibodies failed to detect the endogenous proteins on western blots). These observations are consistent with previous observations of enhanced association of ATP binding-deficient hUpf1 with Smg7, hUpf3a, and hUpf2 (Kashima et al., 2006) . b-actin served as a negative control and did not copurify with wild-type or mutant hUpf1 proteins ( Figure 6A , bottom panel), and none of the endogenous NMD factors nonspecifically copurified with the IP resin (lane 1). When the same assays were repeated in the presence of RNase, Smg5 and Smg7 were the only NMD factors that remained enriched in the mutant hUpf1 complexes, suggesting the accumulation of an RNA-independent interaction between these factors when hUpf1 fails to hydrolyze ATP ( Figure 6A, lanes 9-16) . In addition to NMD factors, both Xrn1 and PABPC1 showed enhanced association with ATPase-deficient hUpf1 proteins over wild-type hUpf1, although this was more evident in the presence than in the absence of RNase-treatment (compare lanes 11 and 12 to lane 10 and lanes 3 and 4 to lane 2). Unlike Xrn1 and NMD factors, PABPC1 was not observed to concentrate in PBs upon ATPase-deficient hUpf1 expression (unpublished data), perhaps because of the high cytoplasmic abundance of PABPC1 overwhelming detection in PBs. Taken together, these observations are consistent with the idea that the hUpf1 ATPase stimulates disassembly of the NMD mRNP. However, some NMD factors show stronger accumulation than others in the trapped mRNP complexes (Figures 5 and 6 ).
NMD Factors Are Associated More Strongly with the 3
0
NMD Fragment in the Presence of ATPase-Deficient Upf1
Finally, to test whether NMD factors can be directly observed in complex with the NMD 3 0 intermediate, individual NMD factors were immunoprecipitated from cells depleted of Xrn1 and expressing the b-39 NMD substrate as well as exogenous wildtype or ATPase-deficient hUpf1 in place of endogenous hUpf1. As seen in the Northern blots in Figure 6B , all tested NMD factors, EJC components, and PABPC1 are found in complex with the 3 0 NMD intermediate (upper panels, band marked by arrow). For the tested NMD factors, the association with the 3 0 intermediate relative to that of full-length b-39 mRNA was enhanced 2.1-6.2-fold in the presence of ATPase-deficient over wild-type hUpf1 (quantifications shown below blots). In contrast, EJC components and PABPC1 showed little or no difference in their association with the 3 0 fragment whether or not hUpf1 can hydrolyze ATP (right panels). These observations suggest that NMD factors are released from the 3 0 fragment by the action of the Upf1 ATPase, whereas release of EJC components and PABPC1 appear to require Xrn1 activity.
DISCUSSION
The Upf1 ATPase Allows NMD mRNP Disassembly Here we have provided several lines of evidence showing that ATP hydrolysis by Upf1 is critical for the disassembly and completed degradation of mRNPs undergoing NMD (Figure 7) . First, mutant Upf1 proteins unable to bind or to hydrolyze ATP cause impaired degradation of NMD substrates and accumulation of a 3 0 intermediate (Figure 1) . Second, the 3 0 intermediate (Figure 2A ) and multiple NMD factors (Figure 6 ) accumulate in complex with Upf1 when it fails to bind or hydrolyze ATP. Third, the NMD mRNA intermediate (Figure 3 with this, Xrn1 appears to be trapped with the NMD mRNP that accumulates upon expression of ATPase-deficient Upf1, as evidenced by the enhanced association of Xrn1 with Upf1 complexes and with PBs under those conditions ( Figures 5A  and 6) (Cho et al., 2009; Isken et al., 2008) . Moreover, the 3 0 NMD mRNP generated in the presence of ATPase-deficient Upf1 is resistant to 5 0 -to-3 0 exonucleolytic decay in vitro unless protein is first removed by phenol extraction ( Figure 2C ). It is unclear where on the accumulating 3 0 NMD mRNP that Upf1 and the NMD complex are positioned. Site-specific RNase H cleavage followed by IP-Northern assays indicated that ATPase-deficient Upf1 is associated with both 5 0 and 3 0 fragments of the b-39 NMD 3 0 mRNP (unpublished data), perhaps reflecting interactions of Upf1 with the EJC and PABPC1 (Figure 6A) as well as directly with the RNA. On the basis of our observations, a simple hypothesis for why NMD shuts down in the presence of ATPase-deficient Upf1 ( Figure 1A ) (Kashima et al., 2006; Weng et al., 1996a Weng et al., , 1996b is that the entrapment of NMD factors on partially degraded NMD mRNPs renders the pathway noncatalytic as a result of the failure of NMD factor recycling. Alternatively, the Upf1 ATPase could be rate-limiting for a more upstream mRNP remodeling step, in which case the accumulation of full-length NMD substrate and 3 0 intermediates in the presence of ATPase-deficient Upf1 reflects a stronger defect in 5 0 -to-3 0 decay than in endonucleolytic cleavage. The effect of the Upf1 ATPase on other mRNA decay activities triggered by NMD, such as decapping and deadenylation, remains to be tested. In either case, our studies illustrate the importance of mRNP disassembly in mRNA turnover.
Although most NMD factors accumulate in PBs ( Figure 5 ) and in association with Upf1 ( Figure 6 ) when Upf1 fails to hydrolyze ATP, Smg5, Smg6, and Smg7 show stronger accumulation than do Upf2, Upf3, and EJC proteins. These weaker associated NMD proteins may either be more loosely associated with the NMD mRNP intermediate, are found at lower stoichiometry in the complex, or are found only on a subset of substrates that require Upf1 ATPase activity for mRNP disassembly. Consistent with the latter idea, Upf1 has been implicated independently of Upf2 and Upf3 in the degradation of mRNAs other than NMD substrates, including histone mRNAs (Kaygun and Marzluff, 2005) and mRNAs associated with Staufen (Kim et al., 2005) . Moreover, evidence has been presented for Upf2-, Upf3-, and EJC-independent NMD pathways in human cells (Bü hler et al., 2006; Chan et al., 2007; Gehring et al., 2005) . The relatively weak accumulation of EJC components could also be a result of EJC disassembly by the recently discovered EJC disassembly activity of the protein PYM (Gehring et al., 2009) .
The mechanism by which the Upf1 ATPase leads to NMD mRNP disassembly remains to be determined. Upf1 could act as a processive RNPase that uses ATPase activity to traverse the mRNA while displacing NMD factors and other RNA-binding proteins from the NMD substrate (Fairman et al., 2004; Jankowsky and Bowers, 2006) . Alternatively, Upf1 could remain stationary and hydrolyze ATP to release itself and other associated factors from the mRNA (Ballut et al., 2005) . Yet another possibility is that ATP hydrolysis by Upf1 acts upstream of a chain of mRNP remodeling events that in the end lead to NMD mRNP disassembly. The observations that Upf1 has highest affinity for RNA in the absence of ATP and shows ATP-dependent 5 0 -to-3 0 RNA translocation activity in vitro (Cheng et al., 2007; Weng et al., 1998) favor the former possibility. However, the observation that the level of NMD intermediate associated with PABPC1 and EJC components, in contrast to NMD factors, is independent of Upf1 ATPase activity ( Figure 6B ), suggests that these factors are not released directly by the Upf1 ATPase but rather at a downstream step, perhaps by the activity of Xrn1 (Figure 7 ). Either way, our observations demonstrate a previously unappreciated step in mRNA decay by which mRNP disassembly allows the completion of exonucleolytic decay and the recycling of mRNP components. The specific mRNP components responsible for blockage of exonucleolytic decay of the NMD substrate in the presence of ATPase-deficient Upf1 remain to be determined. Possible candidates could be the NMD factors themselves or, perhaps, unreleased ribosomes or ribosomal subunits.
Is mRNP Disassembly a Regulated Step in NMD?
Taken together, our observations uncover a previously unappreciated ATP-dependent mRNP disassembly step in mRNP turnover. A key question is what controls the timing of mRNP disassembly in NMD, because slow disassembly would cause accumulation of decay intermediates whereas rapid disassembly could potentially release the NMD mRNP even before it initiates decay. The ATPase activity of human Upf1 is stimulated by the Upf2-Upf3 complex (Chamieh et al., 2008) , and the yeast Upf1 ATPase is repressed by translation release factors eRF3 and eRF1 . Thus, a transition in the NMD mRNP in which Upf1 is released from eRFs and associates with Upf2-Upf3 may precede activation of the Upf1 ATPase and subsequent mRNP disassembly. Consistent with this, ATP binding-deficient Upf1 has been observed to copurify less efficiently than wild-type Upf1 with eRF1 and eRF3 Kashima et al., 2006; Isken et al., 2008) , suggesting that it becomes trapped in a complex lacking eRFs. Moreover, analyses of NMD complexes stalled by NMD factor mutation or depletion have indicated a transition in the human NMD mRNP from a complex between Upf1, Smg1, and eRFs (called SURF) to a complex of NMD factors lacking eRFs (called DECID) (Kashima et al., 2006) . In addition, the phosphorylation and dephosphorylation of metazoan Upf1 seems to be coordinated with the Upf1 ATPase, because ATPase-deficient Upf1 accumulates in a hyperphosphorylated form (Isken et al., 2008; Kashima et al., 2006; Page et al., 1999) , which has been reported to prevent translation reinitiation on the NMD mRNP (Isken et al., 2008) . Why would mRNP disassembly be under such tight control during NMD? This could possibly ensure that NMD factors are released only after mRNA decay factors have already been recruited and/or mRNA decay initiated. This also raises the possibility that ATPase-mediated mRNP disassembly could serve as a previously proposed proofreading step in the NMD pathway (Sheth and Parker, 2006) , in which rapid hydrolysis of ATP by Upf1 would allow the release of the NMD machinery from the mRNA even before initiation of mRNA decay, thus allowing mRNAs wrongly targeted for NMD to be released prior to decay (Figure 7 ). Several lines of evidence suggest that the composition of the mRNP downstream of the translation termination event controls NMD (Amrani et al., 2006; Mü hlemann, 2008; Rebbapragada and Lykke-Andersen, 2009) generally assumed, but also in part by regulating the Upf1 ATPase.
Is mRNP Disassembly Critical for mRNA Turnover Pathways Other Than NMD? Another important question for future studies is whether mRNP disassembly is a critical step in mRNA decay pathways other than NMD. There have been several observations of mRNA and mRNP structures impairing exonucleolytic decay. For example, in S. cerevisiae, both 5 0 -to-3 0 and 3 0 -to-5 0 exonucleolytic decay is impaired by strong RNA secondary structures (Vreken and Raué , 1992; Decker and Parker, 1993; Muhlrad et al., 1995) , and 5 0 -to-3 0 exonucleolytic decay is inhibited by ribosomes stalled by cycloheximide or by rare codons (Beelman and Parker, 1994; Cereghino et al., 1995; Hu et al., 2009) . In Caenorhabditis elegans, 5 0 -to-3 0 decay intermediates of lin-41 mRNA targeted by let-7 microRNA have been observed with the 5 0 end mapping immediately upstream of the let-7-binding sites (Bagga et al., 2005) . Even a heterologous RNA-binding protein, the MS2 coat protein, appears capable of stalling 5 0 -to-3 0 exonucleolytic decay in C. elegans (Liu et al., 2003) . In addition to exonucleolytic decay, PABPC and the cap-binding protein, eIF4E, can inhibit initiation of mRNA decay by deadenylation and decapping, respectively (Schwartz and Parker, 2000; Tucker et al., 2002) . Thus, disassembly of the mRNP is likely to be a critical step in both the initiation and the completion of mRNA turnover. Future studies should reveal the extent to which helicases are involved in these processes. Several helicase proteins have been identified in association with mRNA decay enzymes, including Rck/p54 of the decapping complex and Ski2 of the exosome (Anderson and Parker, 1998; Coller et al., 2001; Fischer and Weis, 2002; Fenger-Grøn et al., 2005) , as well as in association with bacterial and mitochondrial exonucleases (Carpousis, 2007) . Future studies should reveal whether such helicases are important for mRNP disassembly to allow for processivity of their associated mRNA decay enzymes, and whether pathway-specific mRNP disassembly factors are common in mRNA turnover pathways in addition to NMD.
EXPERIMENTAL PROCEDURES
mRNA Decay and RNA Immunoprecipitation Assays Expression of NMD reporter b-39 or GPx1-46 mRNAs was induced for 6 hr by incubation in tetracycline-free medium of HeLa Tet-off cells, depleted of endogenous hUpf1 and/or Xrn1 using siRNAs, and transiently transfected with plasmids expressing tetracycline-regulated b-39 or GPx1-46 mRNAs, and constitutively expressed control b-GAP mRNAs (Figure 1 only) , as well as plasmids expressing siRNA-resistant wild-type or mutant (DEAA or K498A) hUpf1 protein, and in Figure 6B , other tagged NMD factors as indicated (see Extended Experimental Procedures for details). In endogenous mRNA decay assays (Figure 1) , total RNA was prepared from cells using Trizol reagent (Invitrogen), 0, 2, 4, or 6 hr after addition of 1 mg/ml tetracycline to repress NMD reporter mRNA transcription. In in vitro decay assays mediated by Terminator (Figure 2C ), cell extracts prepared in hypotonic gentle lysis buffer, or total RNA prepared from extracts using Trizol, were incubated with Terminator 5 0 -to-3 0 exonuclease (Epicenter) for 0, 5, 10, 20 or 40 min followed by RNA preparation using Trizol. In RNA-immunoprecipitation assays ( Figures  2A and 2B and Figure 6B ), cell extracts prepared in isotonic lysis buffer were subjected to immunoprecipitation against the indicated NMD factors, and RNA from immunoprecipitated samples was isolated using Trizol. NMD substrate levels were analyzed by Northern blotting. (Figure 5 ), as well as with human IC-6 serum, which recognizes endogenous Hedls (P body marker) and Lamin, followed by fluorescently labeled secondary antibodies (antimouse or -rabbit, Alexa 488; anti-human, Texas Red). Cells in Figure 5 express nuclear DsRed to mark transfected cells. For fluorescence in situ hybridization (FISH) assays, cells were hybridized with a mixture of ( Figures 3A and 3C ), or individual ( Figure 3B ), TexasRed-5 0 -labeled 50-nucleotide NMD substrate mRNA antisense DNA probes. Cells for FISH assays express GFP-tagged hDcp1a to mark P bodies (see Extended Experimental Procedures for details).
Indirect Immunofluorescence and Fluorescence
Coimmunoprecipitation Assays
Lysates from HEK293T cells transiently expressing Myc-tagged wild-type or mutant (DEAA or K498A) hUpf1 were subjected, in the presence or absence of RNase A, to anti-Myc immunoprecipitation followed by Western blotting for endogenous NMD factors, Xrn1, PABPC1, or b-actin, or in the case of Smg6, coexpressed HA-tagged Smg6. Bloch are thanked for human IC-6 serum. Dr. Oliver Mü hlemann is thanked for the HA-Smg6 construct. Work on P bodies in our laboratory is supported by funding from grant R01 GM077243 from the National Institutes of Health to J.L.-A. T.M.F. has been supported by National Institutes of Health NRSA Institutional Training grant number GM-07135 from the National Institute of General Medical Sciences.
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